Warren Buffett
Buffett's Masterstroke: OxyChem Deal Models Value Investing in an Overpriced Market
OMAHA, NE & HOUSTON, TX – October 20, 2025 – In a move that has once again underscored his unparalleled acumen for value investing, Warren Buffett's Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) announced in early October 2025 a definitive agreement to acquire Occidental Chemical Corporation (OxyChem), the chemical